
Horizon Technology Finance (HRZN) Stock
Lender funding growth stage technology and life sciences. Here's the price, business snapshot, and what's worth knowing about Horizon Technology Finance in August 2026.
Horizon Technology Finance (HRZN) is a US‑listed business development company (BDC) that provides debt and equity financings to venture‑backed and growth‑stage technology, life sciences and sustainable technology companies. It typically targets later-stage, revenue-generating businesses and aims to deliver current income through interest and the potential for equity upside via warrants or similar instruments. Investors should know that HRZN’s income potential is balanced by elevated credit and equity risk inherent to venture and pre‑IPO financing, along with sensitivity to technology sector cycles. The company’s modest market capitalisation can be associated with lower liquidity and wider share-price swings. Distributions are not guaranteed and may fluctuate with realisations, credit performance and market conditions. This summary is educational only and not personalised advice; investors should consider their time horizon, diversification and risk tolerance and consult a qualified financial adviser before investing.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Horizon Technology Finance Corp's stock with a target price of $6.83, indicating potential growth.
Financial Health
Horizon Technology Finance Corp is performing well, with solid profits and cash flow generation.
Dividend
Horizon Technology Finance Corp's impressive dividend yield of 28.44% makes it very appealing for dividend-seeking investors. If you invested $1000 you would be paid $284.40 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Income and Yield
HRZN aims to generate income through interest and potential equity upside; distributions can fluctuate and are not guaranteed, reflecting credit and market performance.
Tech Growth Exposure
Invests in late‑stage tech and life sciences, offering exposure to innovation while carrying sector cyclicality and elevated credit risk typical of venture financing.
Size and Liquidity
With a modest capitalisation, HRZN may have lower liquidity and wider share-price swings; consider diversification and time horizon when assessing suitability.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.